Long-term outcomes of thoracoscopic lobectomy.

Published

Journal Article (Review)

Thoracoscopic lobectomy is emerging as the procedure of choice for patients with early stage non-small cell lung cancer, based on advantages in quality of life as well as long-term outcomes. In addition, thoracoscopic lobectomy has been demonstrated to be safe and effective for selected patients with locally advanced disease and for those after induction therapy. Concerns relating to oncologic efficacy, as measured by complete resection rate, ability to perform complete mediastinal lymph node dissection, or cancer-specific survival, have not been supported by evidence in the literature. In addition there is increasing evidence that thoracoscopic lobectomy may actually have superior outcomes, based on advantages in morbidity and mortality after resection and in the delivery of adjuvant chemotherapy.

Full Text

Duke Authors

Cited Authors

  • D'Amico, TA

Published Date

  • August 2008

Published In

Volume / Issue

  • 18 / 3

Start / End Page

  • 259 - 262

PubMed ID

  • 18831500

Pubmed Central ID

  • 18831500

International Standard Serial Number (ISSN)

  • 1547-4127

Digital Object Identifier (DOI)

  • 10.1016/j.thorsurg.2008.04.002

Language

  • eng

Conference Location

  • United States